Page 290 - Feline Cardiology
P. 290

Chapter 19: Congestive Heart Failure  297


              used for chronic oral therapy of significant hypokalemia   placed on anticoagulant therapy, and they can be done
              (K < 3 mEq/l). Acid-base abnormalities are also common   ∼2 weeks after initiation of therapy. Recheck echocar-
              in cats with acute heart failure. Metabolic acidosis, diag-  diograms can be done every 3–6 months for assessment
              nosed by low bicarbonate concentration, may reflect low   of atrial size, myocardial function, spontaneous contrast
              output heart failure causing poor tissue perfusion and   or intracardiac thrombus, or pulmonary hypertension.
              lactic  acidosis.  Concurrent  low  venous  oxygen  partial   Progressive, severe atrial dilation despite medical therapy
              pressure  (PvO 2  < 30 mm  Hg)  is  consistent  with  poor   indicates that the patient may be at risk of developing
              tissue  perfusion  and  increased  tissue  extraction  of   refractory heart failure. Myocardial failure may develop
              oxygen. Therapeutic targets are to improve contractility   in  some  patients  that  initially  had  preserved  systolic
              and increase cardiac output. Respiratory acidosis (ele-  function. Patients with myocardial failure are good can-
              vated PCO 2 ) is an ominous sign of impending respira-  didates  for  positive  inodilator  therapy  with  pimoben-
              tory  failure  and  the  potential  need  for  mechanical   dan. Echocardiography is the test of choice to evaluate
              ventilatory support for the fatiguing respiratory muscles.   for development of pulmonary hypertension that may
              Respiratory alkalosis is not uncommon in dyspneic or   develop in animals with severe heart failure. Right ven-
              tachypneic  patients.  Hyperventilation  is  triggered  by   tricular  concentric  and  eccentric  hypertrophy,  right
              hypoxia, stimulation of atrial stretch receptors, or pul-  atrial dilation, pulmonary artery dilation, and increased
              monary  edema  stimulating  pulmonary  nociceptive  J   velocity of tricuspid regurgitation (>3 m/s) are all con-
              receptors, and it usually improves as the edema is cleared.  sistent with the diagnosis of pulmonary hypertension.
                                                                 Sildenafil  (1 mg/kg  PO  q  8 h)  may  reduce  symptoms,
              Monitoring for Recurrent Heart Failure             severity, and frequency of syncope, and reduce pulmo-
              Blood  pressure,  radiographs,  and  blood  chemistry  are   nary artery pressure in animals with significant pulmo-  Congestive Heart Failure
              the  most  essential  diagnostic  tests  to  monitor  during   nary  hypertension  (consider  if  right  ventricle:  right
              acute  and  chronic  heart  failure  therapy.  Vasodilators   atrial pressure gradient >55 mm Hg) (see Chapter 25).
              (ACE  inhibitors)  in  combination  with  other  cardiac
              medications  such  as  furosemide  and  antiarrhythmic   OUTCOME AND PROGNOSIS
              therapy (atenolol or diltiazem) may lead to hypotension
              and may necessitate reduction in dose or discontinua-  Outcome and prognosis include the following:
              tion.  Atenolol  and  diltiazem  are  reserved  for  patients
              with  significant  tachyarrhythmias  because  they  may   •  Heart  failure  is  an  advanced  stage  of  severe  heart
              worsen  acute  heart  failure.  Respiratory  status  may  be   disease.
              simply assessed by monitoring resting respiratory rate   •	 Diseases	 associated	 with	 the	 shortest	 survival	 once
              and effort, while the cat is resting in the cage without   heart	failure	occurs	include	idiopathic	dilated	cardio-
              manipulation. Radiographs are useful to assess for per-  myopathy,	 arrhythmogenic	 right	 ventricular	 cardio-
              sistent  pulmonary  edema  or  pleural  effusion  after   myopathy,	 and	 restrictive	 cardiomyopathy.	 Survival
              diuretic therapy, and helps the clinician plan appropriate   ranges	from	days	to	a	few	months.
              diuretic doses during transition to chronic oral therapy.   •	 Survival	 is	 widely	 variable	 in	 cats	 with	 concurrent
              Assessment of hydration status by physical examination,   hypertrophic	 cardiomyopathy	 and	 congestive	 heart
              PCV/TS, and severity of azotemia or electrolyte derange-  failure	and	ranges	from	months	to	1.5	years	or	longer.
              ments on blood chemistry are essential to form a treat-  •	 Negative	 prognostic	 indicators	 for	 cats	 with	 heart
              ment plan for chronic heart failure therapy.         failure	secondary	to	HCM	include	tachycardia	at	pre-
                 A respiratory log recorded by the owner is a simple   sentation,	(increased)	age,	and	left	atrial	size.
              and  practical  tool  to  monitor  for  recurrence  of  heart
              failure. On a daily basis, the owner records the resting   Survival in cats with heart failure is highly variable and
              respiratory  rate  and  effort,  appetite,  and  clinical   dependent on the etiology of the heart disease. Cats with
              demeanor, and the clinician can review the log intermit-  heart failure secondary to idiopathic dilated cardiomy-
              tently during a phone consultation with the owner. A   opathy, arrhythmogenic right ventricular cardiomyopa-
              resting respiratory rate that is persistently ≥40 breaths/  thy,  or  restrictive  cardiomyopathy  tend  to  have  very
              min increases the clinician’s suspicion of ongoing heart   short survival times and usually succumb within several
              failure and may preempt a recheck or a trial increase of   weeks to months (median survival time: DCM 11 days
              furosemide dose with reassessment of the respiratory log   (Ferasin et al. 2003), ARVC 30 days (Fox et al. 2000),
              a week later.                                      RCM 132 days (Ferasin et al. 2003)). However, survival
                 Recheck  echocardiograms  are  useful  in  cats  with   of cats with heart failure secondary to HCM is highly
              spontaneous contrast or intracardiac thrombi that are   variable.  Median  survival  times  in  two  retrospective,
   285   286   287   288   289   290   291   292   293   294   295